Orexo AB (publ) (STO:ORX)
Sweden · Delayed Price · Currency is SEK 21.40
+0.05 (0.23%)
Jun 16, 2026, 9:14 AM CET
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 745.58 million as of June 15, 2026. Its market cap has increased by 46.79% in one year.
Market Cap
745.58M
Enterprise Value
366.38M
Revenue
17.80M
Ranking
n/a
PE Ratio
1.43
Stock Price
21.40
Market Cap Chart
Since November 9, 2005, Orexo AB's market cap has decreased from 861.50M to 745.58M, a decrease of -13.46%. That is a compound annual growth rate of -0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 745.58M | -28.21% |
| Dec 30, 2025 | 1.04B | 72.00% |
| Dec 30, 2024 | 603.84M | 13.47% |
| Dec 29, 2023 | 532.14M | -17.90% |
| Dec 30, 2022 | 648.17M | -45.27% |
| Dec 30, 2021 | 1.18B | -30.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.59B |
| Cereno Scientific AB | 1.81B |
| Nanexa AB | 825.07M |
| EQL Pharma AB | 724.95M |
| Enzymatica AB | 611.69M |
| Cinclus Pharma Holding AB | 565.90M |
| Dicot Pharma AB | 499.92M |
| Moberg Pharma AB | 474.71M |